EGLN1 and neoplasm: Mazzone et al. reported that hypoxia and the HIF-1α/−2α-associated PHD2 protein could damage MVI [24], and it has been found that gene targeting of Phd2 results in enhanced MVI and improved tumor response to chemotherapy [40].